About 55 million people live with dementia worldwide. New research into why brain cells die is enabling scientists to develop effective Alzheimer’s drugs. About 55 million people worldwide live with some form of dementia —...
The drug aducanumab could be approved in the US and EU soon. It effectively combats the amyloid beta plaques in the brain that are indicative of Alzheimer’s disease. But does it also slow down memory...
Brain training using a specialized computer program can reduce the risk of dementia by almost one third, a newly published study shows. The participants were involved in the training over a ten-year period. Elderly people...
Bioelectronic medicine is embryonic. But British drugmaker GlaxoSmithKline and US tech firm Alphabet see its potential. With one eye on research and another on your data, they will jointly invest millions. Look around the web...
Italians are admired for their healthy Mediterranean diet, but the pressures of modern society mean many are changing their ways. Yet studies show the benefits of eating à la Mediterranean. The Mediterranean diet has for...
Piramal Healthcare Ltd [stockquote]PIRHEALTH[/stockquote] has acquired the molecular imaging development portfolio of Bayer Pharma AG. Its newly created subsidiary called Piramal Imaging SA has entered in to an agreement to acquire the worldwide rights to...